Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tempei Miyaji

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cancer Medicine|November 18, 2024
Nurse-Led Screening-Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled TrialYoshihisa Matsumoto, Shigeki Umemura, Ayumi Okizaki, et al.
BMJ Open|October 8, 2020
Hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled studySadamoto Zenda, Asako Ryu, Atsuo Takashima, et al.
BMJ Open|November 27, 2020
Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trialDaisuke Fujisawa, Shigeki Umemura, Ayumi Okizaki, et al.
BMC Cancer|September 8, 2018
Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trialSadamoto Zenda, Takuhiro Yamaguchi, Tomoya Yokota, et al.
Journal of Gynecologic Oncology|June 29, 2017
Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)Shunsuke Ohnishi, Hidemichi Watari, Maki Kanno, et al.
BMJ Open|February 10, 2023
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and kneeMakoto Endo, Shinya Kawahara, Taishi Sato, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
BMJ Open|November 23, 2023
Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational studyAyumu Matsuoka, Maiko Fujimori, Takafumi Koyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC TrialHironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima, et al.
Breast Cancer (Tokyo, Japan)|July 18, 2025
Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)Hiroko Bando, Aya Ueda, Kaori Terata, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cancer Medicine|November 18, 2024
Nurse-Led Screening-Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled TrialYoshihisa Matsumoto, Shigeki Umemura, Ayumi Okizaki, et al.
BMJ Open|October 8, 2020
Hydrocolloid dressing as a prophylactic use for hand-foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled studySadamoto Zenda, Asako Ryu, Atsuo Takashima, et al.
BMJ Open|November 27, 2020
Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trialDaisuke Fujisawa, Shigeki Umemura, Ayumi Okizaki, et al.
BMC Cancer|September 8, 2018
Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trialSadamoto Zenda, Takuhiro Yamaguchi, Tomoya Yokota, et al.
Journal of Gynecologic Oncology|June 29, 2017
Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)Shunsuke Ohnishi, Hidemichi Watari, Maki Kanno, et al.
BMJ Open|February 10, 2023
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and kneeMakoto Endo, Shinya Kawahara, Taishi Sato, et al.
BMJ Open|November 22, 2023
Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort studyTaiki Hirata, Takashi Kawaguchi, Kanako Azuma, et al.
BMJ Open|November 23, 2023
Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational studyAyumu Matsuoka, Maiko Fujimori, Takafumi Koyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC TrialHironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima, et al.
Breast Cancer (Tokyo, Japan)|July 18, 2025
Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)Hiroko Bando, Aya Ueda, Kaori Terata, et al.
Pageof 6